Viridian Therapeutics, Inc. (VRDN)
24.18
+0.16
(+0.67%)
USD |
NASDAQ |
Aug 25, 16:00
24.18
0.00 (0.00%)
After-Hours: 17:37
Viridian Therapeutics Price : 24.18 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 24.35 | 24.39 | 24.00 | 24.02 | 1.131M |
| Aug 21, 2026 | 24.65 | 24.74 | 24.07 | 24.29 | 906295.0 |
| Aug 20, 2026 | 24.61 | 24.72 | 23.96 | 24.50 | 1.076M |
| Aug 19, 2026 | 24.52 | 24.86 | 23.80 | 24.80 | 1.834M |
| Aug 18, 2026 | 23.00 | 23.95 | 22.84 | 23.93 | 1.993M |
| Aug 17, 2026 | 21.92 | 23.29 | 21.87 | 23.09 | 1.893M |
| Aug 14, 2026 | 22.00 | 22.23 | 21.62 | 22.08 | 1.093M |
| Aug 13, 2026 | 22.70 | 22.86 | 21.89 | 21.99 | 1.768M |
| Aug 12, 2026 | 23.16 | 23.60 | 22.72 | 22.88 | 1.578M |
| Aug 11, 2026 | 23.23 | 23.83 | 22.81 | 22.97 | 3.063M |
| Aug 10, 2026 | 23.46 | 23.57 | 22.78 | 23.06 | 2.269M |
| Aug 07, 2026 | 22.98 | 23.61 | 22.53 | 23.59 | 1.660M |
| Aug 06, 2026 | 20.94 | 22.52 | 20.53 | 22.51 | 4.290M |
| Aug 05, 2026 | 21.00 | 21.34 | 20.60 | 21.07 | 1.667M |
| Aug 04, 2026 | 19.43 | 20.89 | 19.41 | 20.84 | 2.170M |
| Aug 03, 2026 | 18.80 | 19.32 | 18.40 | 19.31 | 1.834M |
| Jul 31, 2026 | 19.66 | 19.90 | 18.89 | 18.92 | 1.088M |
| Jul 30, 2026 | 19.55 | 20.00 | 19.29 | 19.90 | 1.217M |
| Jul 29, 2026 | 19.56 | 19.99 | 19.15 | 19.88 | 2.046M |
| Jul 28, 2026 | 19.67 | 19.95 | 19.11 | 19.51 | 1.101M |
| Jul 27, 2026 | 19.57 | 20.10 | 19.34 | 19.70 | 2.225M |
| Jul 24, 2026 | 19.39 | 19.45 | 19.00 | 19.27 | 1.516M |
| Jul 23, 2026 | 18.87 | 19.60 | 18.61 | 19.26 | 1.347M |
| Jul 22, 2026 | 18.94 | 19.38 | 18.73 | 19.17 | 2.623M |
| Jul 21, 2026 | 18.58 | 19.27 | 18.48 | 19.18 | 1.117M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 30.58 |
| Alnylam Pharmaceuticals, Inc. | 239.95 |
| Anika Therapeutics, Inc. | 21.52 |
| Savara, Inc. | 5.59 |
| Vericel Corp. | 43.17 |
Price Related Metrics
| PS Ratio | 32.83 |
| Price to Book Value | 4.854 |
| Earnings Yield | -15.34% |
| Market Cap | 2.738B |